Variants of concern

Variants of Concern (VOC) are specific mutations or combinations of mutations within a virus that may affect its properties, such as transmissibility, disease severity, immune escape, diagnostic or therapeutic escape, and vaccine effectiveness. These variants are identified and monitored closely by public health organizations worldwide because they may pose a significant risk to public health. The concept of Variants of Concern is particularly relevant in the context of the COVID-19 pandemic, caused by the SARS-CoV-2 virus, although it can apply to any pathogen with the potential for significant impact on human health.

Identification and Classification

Variants of Concern are typically identified through genomic sequencing and epidemiological surveillance. Once a variant is identified, it undergoes a risk assessment based on its characteristics and the potential impact on public health. The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC) in the United States, and other public health agencies have developed criteria for classifying variants into categories such as "Variants Being Monitored," "Variants of Interest," and "Variants of Concern."

Criteria for Classification

A variant is classified as a Variant of Concern when it has been demonstrated to:

• Increase transmissibility or detrimental change in COVID-19 epidemiology
• Increase virulence or change in clinical disease presentation
• Decrease effectiveness of public health and social measures or available diagnostics, vaccines, therapeutics

Examples of Variants of Concern

During the COVID-19 pandemic, several Variants of Concern have been identified, including:

• Alpha variant (B.1.1.7), first identified in the United Kingdom
• Beta variant (B.1.351), first identified in South Africa
• Gamma variant (P.1), first identified in Brazil
• Delta variant (B.1.617.2), first identified in India
• Omicron variant (B.1.1.529), first identified in South Africa

Each of these variants has shown changes in transmissibility, disease severity, or impact on vaccine effectiveness, leading to increased surveillance and, in some cases, adjustments in public health strategies.

Impact on Public Health

Variants of Concern can have significant impacts on public health, including increased rates of transmission, more severe disease, and increased hospitalizations and deaths. They can also affect the effectiveness of vaccines and therapeutics, leading to challenges in controlling the spread of the virus. Public health responses may include enhanced surveillance, increased testing, and adjustments in vaccine composition or vaccination strategies.

Monitoring and Response

Global and national public health organizations monitor the emergence and spread of Variants of Concern through genomic surveillance and epidemiological studies. This monitoring helps inform public health responses, including adjustments to health guidelines, travel advisories, and vaccine strategies. Collaboration among countries and sharing of genomic and epidemiological data are crucial for the timely identification and response to these variants.

‎